QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
40.46
-0.57 (-1.39%)
Feb 21, 2025, 4:00 PM EST - Market closed
QuidelOrtho Revenue
In the year 2024, QuidelOrtho had annual revenue of $2.78B, down -7.17%. QuidelOrtho had revenue of $707.80M in the quarter ending December 29, 2024, a decrease of -4.69%.
Revenue (ttm)
$2.78B
Revenue Growth
-7.17%
P/S Ratio
0.98
Revenue / Employee
$391,958
Employees
7,100
Market Cap
2.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 2.78B | -214.90M | -7.17% |
Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
Jan 3, 2021 | 1.66B | 1.13B | 210.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
QDEL News
- 9 days ago - QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results - Business Wire
- 5 weeks ago - QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 - Business Wire
- 6 weeks ago - Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm - PRNewsWire
- 7 weeks ago - QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - QuidelOrtho Announces Appointment of Two Independent Directors to its Board - Business Wire
- 3 months ago - Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted - Benzinga
- 3 months ago - Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga